The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a firm-fixed price contract for preventative maintenance services for 54 Thermo Fisher Scientific Heracell Vios 160i CO2 incubators. This maintenance agreement is crucial for the Department of Transfusion Medicine, Center for Cellular Engineering Services, which manufactures cell-based therapies for clinical trials and is regulated by the FDA, necessitating that critical equipment is maintained in a controlled manner. The original equipment manufacturer, Thermo Fisher, is uniquely qualified to perform these services, including necessary software updates, to ensure compliance and avoid delays in patient treatments. Interested parties capable of providing similar services must submit a capability statement by November 16, 2024, at 12:00 PM EST to Sheri Eiri at sheri.eiri@nih.gov.